Clinical trials
Hematologic Diseases trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 17 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Active, not recruiting | 12 |
| Recruiting | 11 |
| Terminated | 7 |
| Unknown status | 6 |
| Enrolling by invitation | 3 |
| No longer available | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 8 |
| Seagen Inc. | 6 |
| Vertex Pharmaceuticals Incorporated | 6 |
| Loxo Oncology, Inc. | 5 |
| Gruppo Italiano Trapianto di Midollo Osseo | 4 |
| Pfizer | 4 |
| Swedish Orphan Biovitrum | 3 |
| Takeda | 3 |
| Abbott Medical Devices | 2 |
| Azienda USL Reggio Emilia - IRCCS | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 81 |
| Genetic Diseases, Inborn | 12 |
| Leukemia | 12 |
| Bone Marrow Diseases | 11 |
| Hemorrhagic Disorders | 11 |
| Myeloproliferative Disorders | 11 |
| Anemia | 9 |
| Anemia, Sickle Cell | 9 |
| Blood Coagulation Disorders | 9 |
| Lymphoma, Non-Hodgkin | 9 |
Trials
Showing 51 to 75 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.